Renal/Urology · PANCE / PANRE

Hyponatremia

Serum Na <135 mEq/L; evaluated by volume status and urine osmolality/sodium.

Also known as: hyponatremia, low sodium, SIADH

Overview

Serum sodium concentration <135 mEq/L. Classified by severity (mild 130-134, moderate 125-129, severe <125), acuity (acute <48 h vs chronic), tonicity (hypotonic — true hyponatremia — vs isotonic vs hypertonic pseudohyponatremia), and volume status (hypovolemic, euvolemic, hypervolemic).

Epidemiology

Most common electrolyte abnormality in hospitalized patients (~15-20%). Associated with increased morbidity, mortality, and length of stay across populations.

Try two board-style Hyponatremia questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1RenalMedium
A 65-year-old male with small cell lung cancer has serum sodium 118, urine osmolality 450, urine sodium 60, normal volume status, normal thyroid and adrenal function. Which of the following is the most likely diagnosis?
  • ADiabetes insipidus from ADH deficiency
  • BCerebral salt wasting from CNS injury
  • CSIADH from ectopic ADH secretion
  • DThiazide-induced hyponatremia from diuretic
Reveal answer & full explanation
Correct answer: C — SIADH from ectopic ADH secretion
  • ADiabetes insipidus from ADH deficiency
  • BCerebral salt wasting from CNS injury
  • CSIADH from ectopic ADH secretion
  • DThiazide-induced hyponatremia from diuretic

Why SIADH from ectopic ADH secretion is correct

  • Small cell lung cancer is the most classic cause of ectopic antidiuretic hormone (ADH) secretion, producing syndrome of inappropriate antidiuretic hormone secretion (SIADH).
  • SIADH causes free water retention and euvolemic hyponatremia.
  • Classic lab findings: hyponatremia, inappropriately concentrated urine (osmolality >100, often >300), urine Na >40, normal volume status, low blood urea nitrogen (BUN), low uric acid, normal thyroid and adrenal function — all present in this patient.

Why the others are wrong

  • Diabetes insipidus from ADH deficiency — causes hypernatremia and dilute urine (low urine osmolality) from inability to concentrate urine; opposite of this presentation.
  • Cerebral salt wasting from CNS injury — also causes hyponatremia and high urine sodium but is associated with hypovolemia, not euvolemia, and follows CNS injury, not lung cancer.
  • Thiazide-induced hyponatremia from diuretic — thiazides can cause hyponatremia but there is no mention of diuretic use, and the mechanism differs from ectopic ADH production.

Additional high-yield points

  • Other SIADH causes: CNS pathology (stroke, hemorrhage, infection), pulmonary disease, drugs (SSRIs (selective serotonin reuptake inhibitors), carbamazepine, MDMA, cyclophosphamide), pain/nausea.
  • Treatment hierarchy: fluid restriction (first-line), salt tabs, loop diuretic, hypertonic saline if severe.
  • Correct slowly to avoid osmotic demyelination: maximum 8 mEq/L per 24 hours.
  • Tolvaptan (V2 antagonist) for refractory SIADH.
Question 2RenalMedium
A 62-year-old man with small cell lung cancer is euvolemic with sodium 119 mEq/L, low serum osmolality, high urine osmolality, and high urine sodium. He is confused. Which of the following is the most appropriate treatment?
  • AFree water given orally to dilute sodium
  • BRapid full correction of the sodium
  • CDesmopressin to slow urine output
  • DHypertonic saline with close monitoring
Reveal answer & full explanation
Correct answer: D — Hypertonic saline with close monitoring
  • AFree water given orally to dilute sodium
  • BRapid full correction of the sodium
  • CDesmopressin to slow urine output
  • DHypertonic saline with close monitoring

Why Hypertonic saline with close monitoring is correct

  • Symptomatic hyponatremia at 119 mEq/L with confusion warrants 3% hypertonic saline to lift the sodium enough to relieve cerebral edema.
  • The pattern (euvolemic, low serum osmolality, inappropriately concentrated urine, urine sodium high) is SIADH from ectopic ADH by small cell lung cancer.
  • Close monitoring caps the rise at roughly 6-8 mEq/L per 24 hours to prevent osmotic demyelination.

Why the others are wrong

  • Free water given orally to dilute sodium — Reversal trap: adding free water is retained in SIADH and would drive the sodium lower, worsening the encephalopathy.
  • Rapid full correction of the sodium — Overcorrection trap: normalizing sodium too quickly causes osmotic demyelination syndrome, a feared iatrogenic complication.
  • Desmopressin to slow urine output — Buzzword-reversal trap: desmopressin is an ADH analog that further concentrates urine and deepens the hyponatremia.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Hyponatremia outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Diuretic use, especially thiazides (HCTZ, chlorthalidone)
  • SIADH triggers: malignancy (small cell lung), CNS disease (stroke, hemorrhage, infection), pulmonary disease (pneumonia, TB), drugs (SSRIs, carbamazepine, MDMA, antipsychotics)
  • Heart failure, cirrhosis, nephrotic syndrome (effective arterial underfilling)
  • Adrenal insufficiency, hypothyroidism
  • Polydipsia (psychogenic, beer potomania, tea-and-toast)
  • Postoperative, hypotonic IV fluid administration
  • Exercise-associated hyponatremia (marathon runners over-hydrating with hypotonic fluids)

Pathophysiology

True hypotonic hyponatremia results from excess water relative to sodium. ADH-driven water retention exceeds urinary water excretion capacity. Causes are categorized by volume status: hypovolemic (volume loss replaced with hypotonic fluid), euvolemic (SIADH, hypothyroid, adrenal insufficiency), hypervolemic (HF, cirrhosis, CKD/nephrotic — total body Na increased but water more so). Pseudohyponatremia: severe hyperlipidemia or hyperproteinemia causes lab artifact with normal plasma water Na.

Clinical presentation

Symptoms

  • Mild (130-134): often asymptomatic
  • Moderate (125-129): nausea, headache, fatigue, gait instability
  • Severe (<120 or rapid drop): confusion, seizures, coma, respiratory arrest
  • Symptoms more prominent in ACUTE hyponatremia (rapid decrease); chronic patients may tolerate lower levels

Signs / physical exam

  • Volume status assessment is central to diagnosis
  • Hypovolemic: dry mucous membranes, orthostasis, flat JVP
  • Euvolemic: normal volume exam
  • Hypervolemic: edema, elevated JVP, ascites, crackles
  • Neurologic: altered mental status, focal deficits, hyperreflexia, seizure activity in severe cases

Classic findings

Acute hyponatremia <120 with altered mental status or seizures = emergency requiring 3% hypertonic saline.

Differential diagnosis

  • Hypovolemic hyponatremia — Volume depletion + low urine Na (<20) + high urine osm; GI losses, diuretics (high urine Na if active), bleeding
  • SIADH (euvolemic) — Normal volume, low serum osm, INAPPROPRIATELY concentrated urine (osm >100), urine Na >40, normal thyroid/adrenal function
  • Hypothyroidism / adrenal insufficiency — Test TSH, cortisol; mimic SIADH labs; correct hormone deficit
  • Polydipsia / low solute intake — Dilute urine (<100 mOsm/kg), high water intake (psychogenic) or low solute (beer potomania)
  • Hypervolemic hyponatremia — Edema, ascites; HF, cirrhosis, nephrotic syndrome; urine Na <20 (except CKD)
  • Pseudohyponatremia — Severe hyperlipidemia, hyperproteinemia (multiple myeloma); normal measured osmolality
  • Translocational hyponatremia — Hyperglycemia, mannitol; correct Na = measured Na + 1.6 × ((glucose - 100)/100)

Diagnostic workup

Diagnostic criteria

Serum Na <135 + serum osm <275 = true hypotonic hyponatremia. Etiology determined by volume status + urine osmolality + urine Na (algorithmic approach).

Labs

  • Confirm true hypotonic hyponatremia: measure serum osmolality (low <275 mOsm/kg in true; normal in pseudohyponatremia; high in hyperglycemia or mannitol)
  • Urine osmolality — <100 = primary polydipsia or low solute; >100 = ADH-driven
  • Urine sodium — <20 = volume depletion or low effective volume (HF, cirrhosis); >40 = SIADH, salt-wasting, diuretic, adrenal insufficiency
  • Volume status assessment (clinical exam)
  • TSH, cortisol (or cosyntropin stimulation) to rule out hypothyroidism and adrenal insufficiency
  • BMP for renal function, glucose; uric acid (low in SIADH, high in cerebral salt wasting)

Imaging

  • Chest CT if SIADH suspected to evaluate for malignancy (especially small cell lung)
  • Brain MRI if CNS process suspected as cause

Diagnostic algorithm

flowchart TD
  A[Serum Na <135] --> B[Serum osmolality]
  B -->|Normal/High| C[Pseudohyponatremia<br/>or hyperglycemia/mannitol]
  B -->|Low <275| D[True hypotonic<br/>hyponatremia]
  D --> E[Assess volume status]
  E -->|Hypovolemic| F[Urine Na]
  F -->|<20| G[Extrarenal loss<br/>GI, skin, blood]
  F -->|>40| H[Renal loss<br/>diuretic, adrenal insuff]
  E -->|Euvolemic| I[Urine osm]
  I -->|<100| J[Primary polydipsia<br/>low solute]
  I -->|>100| K[SIADH, hypothyroid,<br/>adrenal insuff]
  E -->|Hypervolemic| L[HF, cirrhosis,<br/>nephrotic, CKD]
Diagnostic algorithm for hyponatremia — serum osmolality, then volume status, then urine studies.

Treatment

First-line

  • Severe symptomatic (seizures, coma, focal neuro deficits):
  • 3% hypertonic saline 100 mL IV bolus, may repeat × 2 every 10 min until symptoms improve; goal is +4-6 mEq/L rise to relieve symptoms
  • Maximum correction 8-10 mEq/L per 24 h (some experts allow up to 12 mEq/L); slower in chronic, malnourished, alcoholic, or hypokalemic patients to avoid osmotic demyelination
  • Treat underlying cause once stable
  • Hypovolemic hyponatremia: isotonic saline (normal saline or lactated Ringer's)
  • Euvolemic hyponatremia (SIADH): fluid restriction (<800-1000 mL/day) first-line; salt tablets or urea if persistent
  • Hypervolemic hyponatremia: fluid + sodium restriction; loop diuretic (furosemide, torsemide); treat underlying HF or cirrhosis
  • Stop offending medications (thiazides, SSRIs)

Second-line / adjunct

  • Vasopressin receptor antagonists (vaptans): tolvaptan (oral), conivaptan (IV) — for refractory SIADH or hypervolemic hyponatremia; monitor closely due to risk of rapid correction
  • Demeclocycline (induces nephrogenic DI) — historical SIADH therapy, rarely used now
  • Treat underlying cause: replace cortisol/thyroid hormone, treat malignancy, manage HF/cirrhosis
  • If overcorrection occurs (Na rises >10-12 mEq/L in 24 h): re-lower with D5W ± DDAVP to prevent osmotic demyelination

Complications

  • Osmotic demyelination syndrome (formerly central pontine myelinolysis) — from overly rapid correction; presents days later with dysarthria, dysphagia, paraparesis, locked-in syndrome; irreversible
  • Cerebral edema and herniation from severe acute hyponatremia
  • Seizures
  • Falls and fractures (chronic mild hyponatremia)
  • Increased mortality in hospitalized patients

PANCE pearls

  • First step in hyponatremia evaluation: check serum osmolality. Low (<275) = true hypotonic; normal = pseudohyponatremia; high = translocational (hyperglycemia, mannitol).
  • SIADH diagnostic criteria: hypotonic hyponatremia + euvolemia + urine osm >100 + urine Na >40 + normal thyroid and adrenal function + no diuretics.
  • Correct chronic hyponatremia SLOWLY: max 8-10 mEq/L per 24 hours to avoid osmotic demyelination syndrome. Higher-risk patients (alcoholics, malnourished, hypokalemic): even more cautious.
  • Acute symptomatic hyponatremia (<48 h): 3% hypertonic saline is appropriate emergency treatment regardless of chronicity concerns.
  • Pseudohyponatremia clue: normal serum osmolality despite low measured Na (lab artifact from hypertriglyceridemia, hyperproteinemia).
  • Hyperglycemia correction formula: corrected Na = measured Na + 1.6 × ((glucose − 100)/100). Each 100 mg/dL glucose rise lowers Na ~1.6 mEq/L.

References

  • European Society 2014 — Clinical practice guideline on diagnosis and treatment of hyponatraemia (Spasovski et al., Eur J Endocrinol 2014)
  • Expert Panel 2013 — Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations (Verbalis et al., Am J Med 2013)

Practice Renal/Urology questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.